BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 30010221)

  • 1. Targeting glypican-4 overcomes 5-FU resistance and attenuates stem cell-like properties via suppression of Wnt/β-catenin pathway in pancreatic cancer cells.
    Cao J; Ma J; Sun L; Li J; Qin T; Zhou C; Cheng L; Chen K; Qian W; Duan W; Wang F; Wu E; Wang Z; Ma Q; Han L
    J Cell Biochem; 2018 Nov; 119(11):9498-9512. PubMed ID: 30010221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Localization of glypican-4 in different membrane microdomains is involved in the regulation of Wnt signaling.
    Sakane H; Yamamoto H; Matsumoto S; Sato A; Kikuchi A
    J Cell Sci; 2012 Jan; 125(Pt 2):449-60. PubMed ID: 22302992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Knockdown of aquaporin-5 sensitizes colorectal cancer cells to 5-fluorouracil via inhibition of the Wnt-β-catenin signaling pathway.
    Li Q; Yang T; Li D; Ding F; Bai G; Wang W; Sun H
    Biochem Cell Biol; 2018 Oct; 96(5):572-579. PubMed ID: 29390193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SMARCAD1 Promotes Pancreatic Cancer Cell Growth and Metastasis through Wnt/β-catenin-Mediated EMT.
    Liu F; Xia Z; Zhang M; Ding J; Feng Y; Wu J; Dong Y; Gao W; Han Z; Liu Y; Yao Y; Li D
    Int J Biol Sci; 2019; 15(3):636-646. PubMed ID: 30745850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rab11a sustains GSK3β/Wnt/β-catenin signaling to enhance cancer progression in pancreatic cancer.
    Yu L; Li X; Li H; Chen H; Liu H
    Tumour Biol; 2016 Oct; 37(10):13821-13829. PubMed ID: 27481517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor suppressor Fbxw7 antagonizes WNT signaling by targeting β-catenin for degradation in pancreatic cancer.
    Jiang JX; Sun CY; Tian S; Yu C; Chen MY; Zhang H
    Tumour Biol; 2016 Oct; 37(10):13893-13902. PubMed ID: 27485116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ZNF281 Promotes Growth and Invasion of Pancreatic Cancer Cells by Activating Wnt/β-Catenin Signaling.
    Qian Y; Li J; Xia S
    Dig Dis Sci; 2017 Aug; 62(8):2011-2020. PubMed ID: 28523575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glypican4 promotes cardiac specification and differentiation by attenuating canonical Wnt and Bmp signaling.
    Strate I; Tessadori F; Bakkers J
    Development; 2015 May; 142(10):1767-76. PubMed ID: 25968312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glypican-5 suppresses Epithelial-Mesenchymal Transition of the lung adenocarcinoma by competitively binding to Wnt3a.
    Wang S; Qiu M; Xia W; Xu Y; Mao Q; Wang J; Dong G; Xu L; Yang X; Yin R
    Oncotarget; 2016 Nov; 7(48):79736-79746. PubMed ID: 27806326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of transient receptor potential channel 5 reverses 5-Fluorouracil resistance in human colorectal cancer cells.
    Wang T; Chen Z; Zhu Y; Pan Q; Liu Y; Qi X; Jin L; Jin J; Ma X; Hua D
    J Biol Chem; 2015 Jan; 290(1):448-56. PubMed ID: 25404731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glypican-6 and Glypican-4 stimulate embryonic stomach growth by regulating Hedgehog and noncanonical Wnt signaling.
    Shi W; Filmus J
    Dev Dyn; 2022 Dec; 251(12):2015-2028. PubMed ID: 36057966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of Wnt/β-catenin signaling in drug resistance of pancreatic cancer.
    Cui J; Jiang W; Wang S; Wang L; Xie K
    Curr Pharm Des; 2012; 18(17):2464-71. PubMed ID: 22372504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cripto-1 contributes to stemness in hepatocellular carcinoma by stabilizing Dishevelled-3 and activating Wnt/β-catenin pathway.
    Lo RC; Leung CO; Chan KK; Ho DW; Wong CM; Lee TK; Ng IO
    Cell Death Differ; 2018 Aug; 25(8):1426-1441. PubMed ID: 29445127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Wnt/β-catenin signalling maintains self-renewal and tumourigenicity of head and neck squamous cell carcinoma stem-like cells by activating Oct4.
    Lee SH; Koo BS; Kim JM; Huang S; Rho YS; Bae WJ; Kang HJ; Kim YS; Moon JH; Lim YC
    J Pathol; 2014 Sep; 234(1):99-107. PubMed ID: 24871033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Glypican proteoglycans show intrinsic interactions with Wnt-3a in human prostate cancer cells that are not always associated with cascade activation.
    de Moraes GFA; Listik E; Justo GZ; Vicente CM; Toma L
    BMC Mol Cell Biol; 2021 May; 22(1):26. PubMed ID: 33947326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Both glypican-3/Wnt/β-catenin signaling pathway and autophagy contributed to the inhibitory effect of curcumin on hepatocellular carcinoma.
    Hu P; Ke C; Guo X; Ren P; Tong Y; Luo S; He Y; Wei Z; Cheng B; Li R; Luo J; Meng Z
    Dig Liver Dis; 2019 Jan; 51(1):120-126. PubMed ID: 30001951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting DCLK1 overcomes 5-fluorouracil resistance in colorectal cancer through inhibiting CCAR1/β-catenin pathway-mediated cancer stemness.
    Wang L; Zhao L; Lin Z; Yu D; Jin M; Zhou P; Ren J; Cheng J; Yang K; Wu G; Zhang T; Zhang D
    Clin Transl Med; 2022 May; 12(5):e743. PubMed ID: 35522902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ERO1L promotes pancreatic cancer cell progression through activating the Wnt/catenin pathway.
    Han F; Xu Q; Zhao J; Xiong P; Liu J
    J Cell Biochem; 2018 Nov; 119(11):8996-9005. PubMed ID: 30076651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of WNT/β-Catenin Signaling Enhances Pancreatic Cancer Development and the Malignant Potential Via Up-regulation of Cyr61.
    Sano M; Driscoll DR; DeJesus-Monge WE; Quattrochi B; Appleman VA; Ou J; Zhu LJ; Yoshida N; Yamazaki S; Takayama T; Sugitani M; Nemoto N; Klimstra DS; Lewis BC
    Neoplasia; 2016 Dec; 18(12):785-794. PubMed ID: 27889647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SOX8 regulates cancer stem-like properties and cisplatin-induced EMT in tongue squamous cell carcinoma by acting on the Wnt/β-catenin pathway.
    Xie SL; Fan S; Zhang SY; Chen WX; Li QX; Pan GK; Zhang HQ; Wang WW; Weng B; Zhang Z; Li JS; Lin ZY
    Int J Cancer; 2018 Mar; 142(6):1252-1265. PubMed ID: 29071717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.